Key result
Short-term immunosuppressive therapy in children with myocarditis was associated with high long-term survival, contrasting with a historical 1-year survival probability of approximately 0.60.
Why the study?
Does short-term immunosuppressive therapy improve long-term survival in children with myocarditis and dilated cardiomyopathy?
Observational
Does short-term immunosuppressive therapy improve long-term survival in children with myocarditis and dilated cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Short-term immunosuppressive therapy may improve long-term survival in children with myocarditis and dilated cardiomyopathy compared to conventional treatment.
Dilated cardiomyopathy (DCM) is a rare disease in the paediatric population. We analysed the epidemiology, clinical features and role of immunotherapy in the treatment of myocarditis. On the basis of experimental evidence, indicating that autoimmunity might play a role in the development of myocarditis, we treated children affected by myocarditis with immunosuppressive therapy, and we present here our series. The future availability of reliable prognostic markers should allow treatment of only those children with myocarditis who do not spontaneously recover. The possibility that DCM with myocarditis is a distinct pathological entity from the non‐inflammatory form of DCM is suggested. Conclusion: The high long‐term survival rate observed in our children with myocarditis is probably due to the effect of short‐term immunosuppression. This result is at odds with previously published series of conventionally treated children, whose survival probability at 1 y was approximately 0.60.
No takes yet. Share an insight, caveat, or question.
Maria Giulia Gagliardi (2006) conducted an observational in Dilated cardiomyopathy and myocarditis. Immunosuppressive therapy vs. Conventional treatment (historical series) was evaluated on Survival probability at 1 year. Short-term immunosuppressive therapy in children with myocarditis was associated with high long-term survival, contrasting with a historical 1-year survival probability of approximately 0.60.
Synapse has enriched 10 related papers. Consider them for comparative context: